ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Regeneus secures ethics approval to collect stem cells for off-the-shelf … – Proactive Investors Australia

Proactive Investors AustraliaRegenerative medicine company Regeneus (ASX: RGS) has received the key ethics approval to collect stem cells from human donors for the production of its new allogeneic off-the-shelf stem cell product for osteoarthritis. It can now begin manufacturing …Regeneus scores stem cells ethics approvalFinance News Network all 2 news articles …read more   &nbs… Continue reading

2014-04-07 Michael Zand NEWS

Regeneus secures ethics approval to collect stem cells for off-the-shelf … – Proactive Investors Australia

Proactive Investors AustraliaRegenerative medicine company Regeneus (ASX: RGS) has received the key ethics approval to collect stem cells from human donors for the production of its new allogeneic off-the-shelf stem cell product for osteoarthritis. It can now begin manufacturing …Regeneus scores stem cells ethics approvalFinance News Network all 2 news articles …read more   &nbs… Continue reading

2014-04-07 Michael Zand NEWS

Stem Cells Show Promise for Stroke Recovery – WebMD

Stem Cells Show Promise for Stroke RecoveryWebMDIt takes multiple steps to get to something clinically useful, and this is a nice, early step,” said Dr. Steven Cramer, clinical director of the Stem Cell Research Center at the University of California, Irvine. The findings were to be presented Monday … and more …read more   &nbs… Continue reading

2014-04-07 Michael Zand NEWS

Stem Cells Show Promise for Stroke Recovery – U.S. News & World Report

Stem Cells Show Promise for Stroke RecoveryU.S. News & World ReportMONDAY, April 7, 2014 (HealthDay News) — In an early test, researchers report they’ve safely injected stem cells into the brains of 18 patients who had suffered strokes. And two of the patients showed significant improvement. All the patients saw some … and more …read … Continue reading

2014-04-07 Michael Zand NEWS

Stem cells show promise for stroke recovery – Medical Xpress

Stem cells show promise for stroke recoveryMedical XpressEarly study found they can be safely transplanted into the brain; 2 patients showed significant improvement. (HealthDay)—In an early test, researchers report they’ve safely injected stem cells into the brains of 18 patients who had suffered strokes … and more …read more   &nbs… Continue reading

2014-04-07 Michael Zand NEWS

Abnormal blood stem cells reprogram their environment – HealthCanal.com

Abnormal blood stem cells reprogram their environmentHealthCanal.comby Koh – Blood arises from stem cells in the bone marrow; in patients with a myelodysplastic disorder (MDS), defective stem cells reprogram their neighbors in the marrow to create a “niche” that promotes their own survival. A recent report by …Stem cell transplantation from unrelated donor saves 2-year-oldTimes … Continue reading

2014-04-07 Michael Zand NEWS

Stem Cells Show Promise for Stroke Recovery – HealthDay

Stem Cells Show Promise for Stroke RecoveryHealthDayMONDAY, April 7, 2014 (HealthDay News) — In an early test, researchers report they’ve safely injected stem cells into the brains of 18 patients who had suffered strokes. And two of the patients showed significant improvement. All the patients saw some … …read more   &nbs… Continue reading

2014-04-07 Michael Zand NEWS

Bonus BioGroup Gains From Start of Clinical Trials of Stem Cell Derived Bone … – Jewish Business News

Bonus BioGroup Gains From Start of Clinical Trials of Stem Cell Derived Bone …Jewish Business NewsBonus Biogroup Ltd. (TASE: BONS), which has developed a method for producing bone grafts from stem cells, has begun a clinical trial of jawbone grafts. The trial’s interim results are due in four months. Bonus Biogroup’s share price rose 10.4% … Continue reading

2014-04-07 Michael Zand NEWS
  • 1
  • …
  • 3,193
  • 3,194
  • 3,195
  • 3,196
  • 3,197
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.